Advances in imaging low-grade gliomas
- 1 January 2010
- book chapter
- Published by Springer Nature
- Vol. 35, 1-34
Abstract
Imaging plays a key role in the management of low-grade gliomas. The traditional view of these tumours as non-enhancing areas of increased signal on T2-weighted imaging is now accepted as being incorrect. Using new MR and PET techniques that can probe the pathological changes with in these tumours by assessing vascularity (perfusion MR), cellularity and infiltration (diffusion weighted and diffusion tensor MR), metabolism (MR spectroscopy and FDG PET) and proliferation (MR spectroscopy, methionine PET and 18Ffluorothymidine FLT PET). These tools will allow improvements in tumour grading, biopsy/therapy guidance and earlier assessment of the response to therapy.Keywords
This publication has 117 references indexed in Scilit:
- Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with gliomaNature Clinical Practice Oncology, 2008
- Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PETNuclear Medicine and Biology, 2008
- High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusionJournal of Magnetic Resonance Imaging, 2007
- Imaging oxygenation of human tumoursEuropean Radiology, 2006
- Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumoursNeuroradiology, 2006
- Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomasClinical Neurology and Neurosurgery, 2005
- Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: Validations for positron emission tomographyNuclear Medicine and Biology, 2004
- Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesionsNeuroradiology, 2002
- Long-term positron emission tomography evaluation of slowly progressive gliomasEuropean Journal of Cancer, 1996
- On the Origin of Cancer CellsScience, 1956